Home‐based transcutaneous electrical acupoint stimulation for high‐normal blood pressure: A randomized controlled trial
Abstract The authors investigated the effectiveness of home‐based transcutaneous electrical acupoint stimulation (TEAS) combined with lifestyle modification on blood pressure (BP) control and explored the feasibility of the trial design in this prospective, randomized controlled trial. The authors r...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-08-01
|
| Series: | The Journal of Clinical Hypertension |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/jch.14496 |
| _version_ | 1797645225778216960 |
|---|---|
| author | Yu Wang Jing‐Wen Yang Jun‐Hong Liu You‐Sheng Qi Jian‐Feng Tu Zhong‐Xue Tian Guang‐Xia Shi Shi‐Yan Yan Li‐Qiong Wang Cun‐Zhi Liu |
| author_facet | Yu Wang Jing‐Wen Yang Jun‐Hong Liu You‐Sheng Qi Jian‐Feng Tu Zhong‐Xue Tian Guang‐Xia Shi Shi‐Yan Yan Li‐Qiong Wang Cun‐Zhi Liu |
| author_sort | Yu Wang |
| collection | DOAJ |
| description | Abstract The authors investigated the effectiveness of home‐based transcutaneous electrical acupoint stimulation (TEAS) combined with lifestyle modification on blood pressure (BP) control and explored the feasibility of the trial design in this prospective, randomized controlled trial. The authors recruited individuals with high‐normal BP who had a systolic blood pressure (SBP) of 120–139 mm Hg and a diastolic blood pressure (DBP) of 80–89 mm Hg, or both. Participants were randomly assigned to receive either lifestyle modification combined with TEAS four times weekly for 12 weeks at home (intervention group) or solely lifestyle modification (control group). The primary outcome was the change in mean SBP at week 12 from the baseline measurement. A total of 60 participants were randomized in a 1:1 ratio, and an intention‐to‐treat analysis was performed on all of the outcomes. The mean difference in the change in SBP for the intervention group (compared to the control) at week 12 was −3.85 mm Hg (95% CI: −7.58 to −.12; p = .043); for the DBP, the change was −2.27 mm Hg (95% CI: −5.76 to 1.23; p = .199). There was no difference in the proportion of progression to hypertension, quality of life, body mass index (BMI) or waist circumference. In addition, two participants reported TEAS‐related adverse events. The authors found a reduction in SBP control in the pragmatic, home‐based intervention by using TEAS combined with lifestyle modification in adults with high‐normal BP. Trial Registration: The study was registered in the Chinese Clinical Trial Registry (ChiCTR 1900024982) on August 6, 2019. |
| first_indexed | 2024-03-11T14:43:17Z |
| format | Article |
| id | doaj.art-58ef5a9f9cfa4dc7bf005b7110bb3644 |
| institution | Directory Open Access Journal |
| issn | 1524-6175 1751-7176 |
| language | English |
| last_indexed | 2024-03-11T14:43:17Z |
| publishDate | 2022-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Journal of Clinical Hypertension |
| spelling | doaj.art-58ef5a9f9cfa4dc7bf005b7110bb36442023-10-30T13:26:05ZengWileyThe Journal of Clinical Hypertension1524-61751751-71762022-08-0124898499210.1111/jch.14496Home‐based transcutaneous electrical acupoint stimulation for high‐normal blood pressure: A randomized controlled trialYu Wang0Jing‐Wen Yang1Jun‐Hong Liu2You‐Sheng Qi3Jian‐Feng Tu4Zhong‐Xue Tian5Guang‐Xia Shi6Shi‐Yan Yan7Li‐Qiong Wang8Cun‐Zhi Liu9International Acupuncture and Moxibustion Innovation Institute Beijing University of Chinese Medicine Chaoyang District Beijing ChinaInternational Acupuncture and Moxibustion Innovation Institute Beijing University of Chinese Medicine Chaoyang District Beijing ChinaHeyi Community Health Service Center Fengtai District Beijing ChinaHeyi Community Health Service Center Fengtai District Beijing ChinaInternational Acupuncture and Moxibustion Innovation Institute Beijing University of Chinese Medicine Chaoyang District Beijing ChinaInternational Acupuncture and Moxibustion Innovation Institute Beijing University of Chinese Medicine Chaoyang District Beijing ChinaInternational Acupuncture and Moxibustion Innovation Institute Beijing University of Chinese Medicine Chaoyang District Beijing ChinaInternational Acupuncture and Moxibustion Innovation Institute Beijing University of Chinese Medicine Chaoyang District Beijing ChinaInternational Acupuncture and Moxibustion Innovation Institute Beijing University of Chinese Medicine Chaoyang District Beijing ChinaInternational Acupuncture and Moxibustion Innovation Institute Beijing University of Chinese Medicine Chaoyang District Beijing ChinaAbstract The authors investigated the effectiveness of home‐based transcutaneous electrical acupoint stimulation (TEAS) combined with lifestyle modification on blood pressure (BP) control and explored the feasibility of the trial design in this prospective, randomized controlled trial. The authors recruited individuals with high‐normal BP who had a systolic blood pressure (SBP) of 120–139 mm Hg and a diastolic blood pressure (DBP) of 80–89 mm Hg, or both. Participants were randomly assigned to receive either lifestyle modification combined with TEAS four times weekly for 12 weeks at home (intervention group) or solely lifestyle modification (control group). The primary outcome was the change in mean SBP at week 12 from the baseline measurement. A total of 60 participants were randomized in a 1:1 ratio, and an intention‐to‐treat analysis was performed on all of the outcomes. The mean difference in the change in SBP for the intervention group (compared to the control) at week 12 was −3.85 mm Hg (95% CI: −7.58 to −.12; p = .043); for the DBP, the change was −2.27 mm Hg (95% CI: −5.76 to 1.23; p = .199). There was no difference in the proportion of progression to hypertension, quality of life, body mass index (BMI) or waist circumference. In addition, two participants reported TEAS‐related adverse events. The authors found a reduction in SBP control in the pragmatic, home‐based intervention by using TEAS combined with lifestyle modification in adults with high‐normal BP. Trial Registration: The study was registered in the Chinese Clinical Trial Registry (ChiCTR 1900024982) on August 6, 2019.https://doi.org/10.1111/jch.14496acupuncturehigh‐normal blood pressurelifestyle interventionsprehypertensiontranscutaneous electrical acupoint stimulation |
| spellingShingle | Yu Wang Jing‐Wen Yang Jun‐Hong Liu You‐Sheng Qi Jian‐Feng Tu Zhong‐Xue Tian Guang‐Xia Shi Shi‐Yan Yan Li‐Qiong Wang Cun‐Zhi Liu Home‐based transcutaneous electrical acupoint stimulation for high‐normal blood pressure: A randomized controlled trial The Journal of Clinical Hypertension acupuncture high‐normal blood pressure lifestyle interventions prehypertension transcutaneous electrical acupoint stimulation |
| title | Home‐based transcutaneous electrical acupoint stimulation for high‐normal blood pressure: A randomized controlled trial |
| title_full | Home‐based transcutaneous electrical acupoint stimulation for high‐normal blood pressure: A randomized controlled trial |
| title_fullStr | Home‐based transcutaneous electrical acupoint stimulation for high‐normal blood pressure: A randomized controlled trial |
| title_full_unstemmed | Home‐based transcutaneous electrical acupoint stimulation for high‐normal blood pressure: A randomized controlled trial |
| title_short | Home‐based transcutaneous electrical acupoint stimulation for high‐normal blood pressure: A randomized controlled trial |
| title_sort | home based transcutaneous electrical acupoint stimulation for high normal blood pressure a randomized controlled trial |
| topic | acupuncture high‐normal blood pressure lifestyle interventions prehypertension transcutaneous electrical acupoint stimulation |
| url | https://doi.org/10.1111/jch.14496 |
| work_keys_str_mv | AT yuwang homebasedtranscutaneouselectricalacupointstimulationforhighnormalbloodpressurearandomizedcontrolledtrial AT jingwenyang homebasedtranscutaneouselectricalacupointstimulationforhighnormalbloodpressurearandomizedcontrolledtrial AT junhongliu homebasedtranscutaneouselectricalacupointstimulationforhighnormalbloodpressurearandomizedcontrolledtrial AT youshengqi homebasedtranscutaneouselectricalacupointstimulationforhighnormalbloodpressurearandomizedcontrolledtrial AT jianfengtu homebasedtranscutaneouselectricalacupointstimulationforhighnormalbloodpressurearandomizedcontrolledtrial AT zhongxuetian homebasedtranscutaneouselectricalacupointstimulationforhighnormalbloodpressurearandomizedcontrolledtrial AT guangxiashi homebasedtranscutaneouselectricalacupointstimulationforhighnormalbloodpressurearandomizedcontrolledtrial AT shiyanyan homebasedtranscutaneouselectricalacupointstimulationforhighnormalbloodpressurearandomizedcontrolledtrial AT liqiongwang homebasedtranscutaneouselectricalacupointstimulationforhighnormalbloodpressurearandomizedcontrolledtrial AT cunzhiliu homebasedtranscutaneouselectricalacupointstimulationforhighnormalbloodpressurearandomizedcontrolledtrial |